US Stem Cell Research Policy

Principles of Regenerative Medicine 3rd edition, edited by Anthony Atala, Robert Lanza, Tony Mikos, Robert Nerem, 1309-1329. Cambridge, MA: Academic Press, 2018.

21 Pages Posted: 29 Sep 2020 Last revised: 22 Dec 2021

See all articles by Josephine Johnston

Josephine Johnston

The Hastings Center

Rachel Zacharias

University of Pennsylvania Law School

Date Written: September 1, 2018

Abstract

Since their discovery, human stem cells have remained a point of discussions in science and health policy. They are thought to have considerable potential for the treatment of many diseases, but particularly when derived from human embryos, they raise ethical issues. In this chapter, we identify four main sources of human stem cells and examine the ethical and policy implications of research and treatment use of cells from those sources. We then outline the evolving state, federal, and international laws, policies, and guidelines surrounding human stem cell research, specifically focusing on the most ethically challenging source of stem cells: human embryos. We conclude with a discussion of three ethical, legal, social, and policy issues: compensation of egg donors, commercialization of and access to stem cell therapies, and the creation of animal–human chimeras.

Suggested Citation

Johnston, Josephine and Zacharias, Rachel, US Stem Cell Research Policy (September 1, 2018). Principles of Regenerative Medicine 3rd edition, edited by Anthony Atala, Robert Lanza, Tony Mikos, Robert Nerem, 1309-1329. Cambridge, MA: Academic Press, 2018. , Available at SSRN: https://ssrn.com/abstract=3672679 or http://dx.doi.org/10.2139/ssrn.3672679

Josephine Johnston

The Hastings Center ( email )

Garrison, NY 10524
United States

Rachel Zacharias (Contact Author)

University of Pennsylvania Law School ( email )

3501 Sansom St
Philadelphia, PA 19104
United States

Do you have a job opening that you would like to promote on SSRN?

Paper statistics

Downloads
1
Abstract Views
97
PlumX Metrics